Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.00K | 0.00 | 18.18K | 64.84K | 2.29M | 1.97M |
Gross Profit | -213.00 | -213.00 | -12.72K | 61.68K | 322.01K | 154.07K |
EBITDA | -301.17K | -387.17K | -719.49K | -314.25K | -114.43K | -981.88K |
Net Income | -385.72K | -516.72K | -843.63K | -574.70K | -543.45K | -1.66M |
Balance Sheet | ||||||
Total Assets | 1.59M | 864.50K | 1.32M | 1.79M | 2.33M | 3.26M |
Cash, Cash Equivalents and Short-Term Investments | 53.00K | 8.91K | 17.15K | 12.75K | 246.19K | 27.97K |
Total Debt | 4.28M | 3.42M | 4.45M | 4.69M | 4.82M | 6.13M |
Total Liabilities | 4.52M | 3.70M | 4.67M | 5.06M | 5.30M | 6.68M |
Stockholders Equity | -2.92M | -2.84M | -3.35M | -3.27M | -2.96M | -3.42M |
Cash Flow | ||||||
Free Cash Flow | -1.43M | -909.75K | -642.97K | -352.84K | 939.92K | 555.22K |
Operating Cash Flow | -1.43M | -909.75K | -617.97K | -352.84K | 940.52K | 556.21K |
Investing Cash Flow | 0.00 | 927.25K | 624.62K | 352.50K | -599.00 | -986.00 |
Financing Cash Flow | 1.24M | -25.74K | -2.26K | -233.10K | -721.70K | -560.06K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | £3.83B | 14.32 | 7.71% | 668.34% | 15.42% | 4.45% | |
70 Outperform | £3.96B | 18.02 | 4.92% | 611.79% | -3.22% | -37.21% | |
66 Neutral | £962.26M | 14.54 | 2.04% | 234.64% | 11.04% | 38.13% | |
65 Neutral | £213.07M | 12.88 | 5.65% | 161.99% | 13.91% | -2.75% | |
64 Neutral | £3.12B | 21.24 | 4.22% | 116.77% | -11.63% | -31.81% | |
52 Neutral | £472.40M | ― | -9.56% | 97.23% | -3.50% | -176.18% | |
31 Underperform | £404.96K | ― | ― | 446.45% | 59.09% |